Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6301 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
78-7   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-8   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-9   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-10   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-11   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-12   Tenelia Mitsubishi Tanabe Pharma Corporation Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-13   Iomeron (典迈伦) Bracco Imaging Italia S.r.L. Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-14   Iomeron (典迈伦) Bracco Imaging Italia S.r.L. Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-15   Glycophos (格利福斯) Fresenius Kabi SSPC Manufactured by the approved original foreign company in China Original drug locally manufactured in China The 78th Batch of Reference Listed Drugs
78-16   / Dr Reddys Laboratories SA Internationally recognized to be equivalent to the original drug US Orange Book The 78th Batch of Reference Listed Drugs